201 - 225 of 1,277
Number of results to display per page
TitleCreatorRelation Is Part Of
201 Platform Presentation: Ganglion Cell Layer Volume by Spectralis Optical Coherence 375 Tomography (OCT) in Multiple SclerosisEmma Davies; Dina Jacobs; James Wilson; Clyde Markowitz; Steven Galetta; Elliot Frohman; Peter Calabresi; Laura BalcerNANOS 2010: IV OCT in Neuroophthalmology Practice
202 Spectral Oximetry Measured with Ultra-high Resolution Optical Coherence Tomography in Multiple SclerosisHong Jiang; Yufeng Ye; Delia Cabrera DeBuc; Meixiao Shen; Byron Lam; Lili Ge; Jianhua WangNANOS 2012: Poster Presentations
203 Third Ventricular Width and Retinal Nerve Fiber Layer Thickness in Multiple SclerosisJohn H. Pula; Jason Kam; Jorge Kattah; Jeffrey DeSanto; Rob Motl; Jacob Sosnoff; Huaping Wang NANOS 2012: Poster Presentations
204 Time-Domain and Spectral Domain Optical Coherence Tomography of Retinal Nerve Layer Thickness in MS Patients and Healthy ControlsAlex Lange; Reza Sadjadi; Jameelah Saeedeh; Janette Lindley; Fiona Costello; Anthony TraboulseeNANOS 2011: Poster Presentations
205 Understanding Optic Neuritis from Murine Models of Multiple SclerosisOana M. Dumitrascu; Homayon GhiasiNANOS 2014: Poster Presentations
206 What Eye Movements Teach Us about Chiari Type II MalformationMichael Salman; James Sharpe; Maureen Dennis; Martin SteinbachNANOS 2008: Platform Session II
207 MULES on the Sidelines: A Vision-Based Assessment Tool for Sports-Related ConcussionLisena Hasanaj; Samuel Fallon; Darlina Liu; Omar Akhand; John Martone; Julie Giles; Rachel Nolan; Nikki Webb; Julia Drattell; Liliana Serrano; John-Ross Rizzo; Janet Rucker; Dennis Cardone; Steven Galetta; Laura BalcerNAM 2019: Poster Session II: Scientific Advancements in Neuro-Ophthalmology
208 Ophthalmological Literature of Neuro-Ophthalmological SignificanceHelen Danesh-Meyer, MD, PhD, FRANZCONANOS Annual Meeting 2018: Literature Review
209 Contribution of Structural and Functional Visual Outcomes to Work Capacity and Employment Status in Multiple SclerosisDavid Sackel; Dina Jacobs; Lauren Talman; Amy Conger; James Wilson; Clyde Markowitz; Peter Calabresi; Elliot Frohman; Steven Galetta; Ralph Benedict; Sarah Morrow; Laura BalcerNANOS 2010: Poster Presentations
210 Emerging Therapies of Multiple SclerosisJeffrey Bennett, MD, PhDNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
211 Existing Therapies for Treatment of MSAri J. Green, MDNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
212 Five- to Seven-Year Longitudinal Data for Vision and OCT Retinal Nerve Fiber Layer (RNFL) Thickness in MSStephen J. Moster; Lauren Talman; James Wilson; Kristin Galetta; Reiko Sakai; Steven L. Galetta; Elliot Frohman; Peter Calabresi; Laura J. BalcerNANOS 2012: Scientific Platform Presentations (Session I)
213 The Impact of Acetylcholine Receptor Antibody Titers in Acetylcholine Receptor Antibody-Positive Ocular Myasthenia Gravis: Generalization, Presence of Thyroid Autoimmune Antibodies, and ThymomaMontana Supawongwattana; Kavin Vanikieti; Panitha Jindahra; Tanyatuth PadungkiatsagulNANOS Annual Meeting 2023: Scientific Platform Session I: https://novel.utah.edu/collection/NAM/toc/
214 Multiple Sclerosis Patients With Depression Are More Likely To Subjectively Rate Their Vision Poorly (.pdf)Meagan D. Seay; Fan Youran; Robert A. BermelNANOS Annual Meeting 2016: Poster Presentations
215 Neuroprotective Effects of ST266 in Experimental Optic Neuritis (.pdf)Kenneth S. Shindler; Reas S Khan; Kimberly Dine; Larry BrownNANOS Annual Meeting 2016: Scientific Platform Session II
216 New Therapies for Multiple Sclerosis, Beyond the ABCsAri J. GreenNANOS Annual Meeting Journal Club, 2015
217 New Therapies for Multiple Sclerosis, Beyond the ABCs (video)Ari J. GreenNANOS Annual Meeting Journal Club, 2015
218 Ocular Motor Abnormalities during Saccadic Reading in Different Neuro-Ophthalmic DiseasesAngela Oh; Tiffany Chen; Mohammad Shariati; Naz Jehangir; Caroline Yu; Carmel Mercado; Rosa Yu; Joyce LiaoNANOS Annual Meeting 2018: Scientific Platform, Session I
219 Platform Presentation: The SIRT1 Activator SRT501 Attenuates Retinal Ganglion Cell Loss and Preserves Axonal Function During Acute Optic NeuritisKenneth S. Shindler; Elvira Ventura; Peter Elliott; A. M. RostamiNANOS 2007: NANOS Platform Presentation
220 The predictive value of brain MRI in acute optic neuritis for developing multiple sclerosisJette L. Frederiksen; Nadia N. PoulsenNANOS 2014: Poster Presentations
221 Retinal Nerve Fiber Layer (RNFL) Thickness by Optical Coherence Tomography (OCT) in Multiple Sclerosis (MS): Relation to Visual Function Using Current vs. High-Resolution TechnologiesJennifer Graves; Lauren Talman; Amy Conger; Stephanie Syc; Dina Jacobs; Clyde Markowitz; Yang Dai; Gui-Shuang Ying; Steven Galetta; Elliot Frohman; Peter Calabresi; Laura BalcerNANOS 2010: Poster Presentations
222 Single-Cell Repertoire Analysis Demonstrates Clonal Expansion of the B Cell Response in Optic NeuritisJeffrey L. Bennett, MD, PhD; Kurt Haubold, PhD; Gregory P. Owens, PhD; Donald H. Gilden, MDNANOS 2004: Scientific Platform Presentations (Session 3)
223 Structure-Function Analysis in Chiasmal Compression Helps Predict Visual Prognosis (.pdf)Juthamat Witthayaweerasak; Jennifer Li; Ming-Hui Sun; M. Ali Shariati; Yaping Joyce LiaoNANOS Annual Meeting 2016: Poster Presentations
224 MOG Positive Optic Neuritis with a Phenotype of CRION DiseaseAma Sadaka; Jaspreet Jakhu; Nagham Al-Zubidi; Rosa Tang; Jade SchiffmanNANOS 2018: Poster Presentations
225 Relapsing-Remitting Multiple Sclerosis and Intermediate Uveitis Treated with NatalizumabJieun Kang; Tamer Ghanayem; Alexis Flowers; Subramaniam Sriram; Akshay Thomas; Sapna Gangaputra; Shailee ShahNANOS Annual Meeting 2023: Poster Session I: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases
201 - 225 of 1,277